a. Treatment with commonly used therapies has been associated with the emergence of atovaquone- and azithromycin-resistant B. microti. [Clearly, none
They looked at treatments like mefloquine [Larium], tafenoquine [Arakoda}, primaquine, methylene blue, and lumefantrine [Coartem], alone or in combination with
Borrelia afzelii and Borrelia garinii are the leading causes of Lyme borreliosis (LB) in Europe. Persistent LB forms may involve
How do we know 70-80% are cured with two weeks of Doxycycline and Amoxicillin? These meds push active Lyme into
In recent years, Babesia and Bartonella species co-infections in patients with chronic, nonspecific illnesses have continued to challenge and change
Dr. Eva Sapi, Chair of the Department of Biology and Environmental Sciences at the University of New Haven, has led
Dr. Neil L. Spector, MD, was a leading physician-scientist, Duke University oncologist, and cancer researcher whose personal encounter with tick-borne
Timothy Haystead, PhD, professor of pharmacology and cancer biology, has been honored with the inaugural Neil L. Spector, MD, Legacy
Why Do Infection Doctors Not Focus On Forms That Are Not The Basic Active Form? The existence of round bodies
Among physicians, James L. Schaller, MD is unusual in having authored publications that collectively address Babesia, Bartonella, Lyme disease, mold
